Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167204 · ClinicalTrials.gov registry record · NA
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02167204: Completed NA study, sponsored by University of Washington.
NCT02167204 is a NA study that has completed, run by University of Washington. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02167204, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This pilot clinical trial studies fluorine F 18 fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) in measuring cell proliferation in patients with brain tumors. Comparing results of diagnostic procedures done before, during, and after treatment may help doctors measure tumor growth and plan the best treatment.
Primary Outcome
The percentage change in the kinetic model parameter of FLT flux (Ki) was recorded. Ki is estimated from parameters derived by fitting the FLT input function and the total blood activity curve to the tissue time-activity curve data.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Positron Emission Tomography
- RADIATION Fluorothymidine F-18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-01-21 |
| Phase | NA |
What the finished NCT02167204 record still lists
NCT02167204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Computed Tomography is the first listed.
NCT02167204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02167204 about?
NCT02167204 is a clinical study titled "18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors". This pilot clinical trial studies fluorine F 18 fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) in measuring cell proliferation in patients with brain tumors. Comparing results of diagnostic procedures done before, during, and after treatment may help doctors measur...
What is the current status of trial NCT02167204?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-11. Estimated completion is 2019-01-21.
What interventions are being tested in trial NCT02167204?
The interventions under investigation include: Computed Tomography (PROCEDURE), Positron Emission Tomography (PROCEDURE), Fluorothymidine F-18 (RADIATION).
Who is sponsoring clinical trial NCT02167204?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02167204's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia